Cornerstone Wealth Management, LLC Moderna, Inc. Transaction History

Cornerstone Wealth Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	SELL	$85.37 - $115.44 $23,903 - $32,323	-280 Reduced 9.94%	2,537 $270,000
Q4 2023 Jan 10, 2024	BUY	$69.51 - $104.43 $278 - $417	4 Added 0.14%	2,817 $280,000
Q3 2023 Nov 06, 2023	SELL	$96.41 - $126.61 $14,365 - $18,864	-149 Reduced 5.03%	2,813 $290,000
Q2 2023 Jul 14, 2023	SELL	$118.5 - $160.53 $70,981 - $96,157	-599 Reduced 16.82%	2,962 $359,000
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $86,551 - $125,698	638 Added 21.83%	3,561 $546,000
Q2 2022 Aug 04, 2022	BUY	$117.13 - $176.59 $8,550 - $12,891	73 Added 2.56%	2,923 $418,000
Q1 2022 Apr 21, 2022	SELL	$126.46 - $235.05 $58,803 - $109,298	-465 Reduced 14.03%	2,850 $491,000
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $33,873 - $55,276	-150 Reduced 4.33%	3,315 $841,000
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $210,805 - $460,246	950 Added 37.77%	3,465 $1.33 Million
Q2 2021 Aug 09, 2021	SELL	$129.91 - $234.98 $14,420 - $26,082	-111 Reduced 4.23%	2,515 $591,000
Q1 2021 Apr 30, 2021	BUY	$109.18 - $185.98 $286,706 - $488,383	2,626 New	2,626 $344,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Cornerstone Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cornerstone Wealth Management, LLC with notifications on news.